*Vermont’s Senate voted 26-2 to pass a state GMO labeling policy which will go into effect in July 2016. The bill will have to be voted again in the House (where it’s already passed). The governor has said he’ll sign it.
*The Grocery Manufacturers Association’s preemption bill against GMO labeling has been introduced in Congress. I wrote a full analysis here. This federal preemption policy would enlist the FDA to ban the states from enacting any kind of truth-in-labeling laws. Instead the FDA would be given new propaganda tools to continue its fraudulent pretense that it undertakes any “regulation” of GMOs whatsoever.
That the FDA does anything at all to assess the safety of GMOs and other agricultural poisons is one of the core lies of the GMO hacks. In truth the FDA has never once performed or required a single test. But it has always implicitly endorsed the lie that it does do such testing. The GMA bill is designed to intensify this campaign of lies.
*Testbiotech has released a thorough assessment of how all alleged “study” considered by the EFSA on the GM maize variety 1507 has been controlled by the cartel, either directly or through revolving door personnel posing fraudulently as “independent” researchers. 1507 may be approved in May in spite of the lack of any safety testing at all, as well as its rejection in votes by the European Parliament and European Council.
*As I’ve predicted several times before, the EC is moving to constrain and render impracticeable its “subsidiarity” policy (cf. especially p. 6 and 10-11 of the PDF) under which EU member states can institute state-level bans on the cultivation of a GM crop approved at the EU level by the Commission. Currently only the MON810 maize variety is approved for cultivation in the EU. It has been banned by ten countries, and is widely grown only in Spain.
But under the proposed policy change, each country would be required to make a special bureaucratic request of the applying corporation for each individual application, a priori, asking that its own territory be excluded from the scope of the application. Only if the applicant refuses will the member state then be allowed to enact its own ban. The technical criteria for such a ban to be valid in the bureaucratic courts would also be tightened. The policy proposal would further erode the Precautionary Principle and further exalt the preemptive power of EFSA assessments. The revolving door EFSA is little more than a Monsanto division.
Obviously this is meant to be cumbersome to the point of impossibility. Instead of taking cultivation approvals on a case by case basis, a national government is supposed to track down every pending application, assess its approval in a hypothetical way, make a future-oriented decision, and formulate a request. And who is supposed to do this – a bureaucracy which is naturally more likely to support the corporate project than a legislature which is more likely to be responsive to the public good. And then there’s the fact that the government of a day is to be able to tie the hands of its successors in perpetuity. Once again we see the fundamental hostility of the EC to democracy and to politics as such.
*GeneWatch UK is filing Freedom of Information requests, and now a complaint with the Information Commissioner, demanding access to withheld and redacted parts of communications between the government’s Department of the Environment, Farms, and Rural Affairs (Defra) and the GMO cartel’s lobby group the Agricultural Biotechnology Council (ABC). The information already released details coordinated media strategies and how the government keeps the lobby informed about upcoming minister speeches and policy proposals. It’s clear that little will be needed from TTIP “regulatory coherence” to increase the intensity of government/corporate bureaucratic Gleichschaltung in the UK.
*A detailed account of the politics of how over 200 GM field trials were okayed in India earlier this year.
*I’m sure we’re all very sorry about the news that parasite commodity traders have “lost” as much $427 million in reduced US maize exports to China, because the US commodification system is incompetent to provide the uncontaminated products the buyer requests. This is a severe indictment of the entrepreneurial abilities of US commodifiers. Now the traders are squabbling with the GMO cartel about why it’s not possible to segregate the particular variety China has been rejecting, Syngenta’s MIR162 line.
The answer, of course, is that the commodification system is unsuited to provide versatility and diversity because it’s designed to supply the opposite, an undifferentiated monoculture commodity flow. Even more importantly, this proves contamination by unwelcome GMOs at every point of the growth and supply chain is inevitable. Over the long run segregation is impossible, just as “coexistence” in general is impossible. In some cases like this one, it’s evidently impossible even in the immediate run.